Recombinant multi-species Caspr2/CNTNAP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Caspr2/CNTNAP2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
The Alternative Names of target: 5430425M22Rik,AUTS15,CASPR,CASPR2,CDFE,CNTNAP2,Caspr2,Cell recognition molecule Caspr2,Cntnap2,Contactin-associated protein-like 2,NRXN4,PTHSL1,mKIAA0868

Target products collectionGo to Caspr2/CNTNAP2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0587-Ag-1/ GM-Tg-hg-IP0587-Ag-2 Human Caspr2/CNTNAP2 protein Human
GM-Tg-rg-IP0587-Ag-1/ GM-Tg-rg-IP0587-Ag-2 Rat Caspr2/CNTNAP2 protein Rat
GM-Tg-mg-IP0587-Ag-1/ GM-Tg-mg-IP0587-Ag-2 Mouse Caspr2/CNTNAP2 protein Mouse
GM-Tg-cynog-IP0587-Ag-1/ GM-Tg-cynog-IP0587-Ag-2 Cynomolgus/Rhesus macaque Caspr2/CNTNAP2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0587-Ag-1/ GM-Tg-felg-IP0587-Ag-2 Feline Caspr2/CNTNAP2 protein Feline
GM-Tg-cang-IP0587-Ag-1/ GM-Tg-cang-IP0587-Ag-2 Canine Caspr2/CNTNAP2 protein Canine
GM-Tg-bovg-IP0587-Ag-1/ GM-Tg-bovg-IP0587-Ag-2 Bovine Caspr2/CNTNAP2 protein Bovine
GM-Tg-equg-IP0587-Ag-1/ GM-Tg-equg-IP0587-Ag-2 Equine Caspr2/CNTNAP2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0587-Ag-1/ GM-Tg-hg-IP0587-Ag-2; GM-Tg-rg-IP0587-Ag-1/ GM-Tg-rg-IP0587-Ag-2;
GM-Tg-mg-IP0587-Ag-1/ GM-Tg-mg-IP0587-Ag-2; GM-Tg-cynog-IP0587-Ag-1/ GM-Tg-cynog-IP0587-Ag-2;
GM-Tg-felg-IP0587-Ag-1/ GM-Tg-felg-IP0587-Ag-2; GM-Tg-cang-IP0587-Ag-1/ GM-Tg-cang-IP0587-Ag-2;
GM-Tg-bovg-IP0587-Ag-1/ GM-Tg-bovg-IP0587-Ag-2; GM-Tg-equg-IP0587-Ag-1/ GM-Tg-equg-IP0587-Ag-2
Products Name Caspr2/CNTNAP2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Caspr2/CNTNAP2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Caspr2/CNTNAP2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.